Form 4: Twist Bioscience Executive Awarded Restricted Stock Units

Robert F. Werner, Chief Accounting Officer of Twist Bioscience, received 8,438 restricted stock units (RSUs) on December 4, 2024.

Summary

• Robert F. Werner, the Chief Accounting Officer of Twist Bioscience, was granted 8,438 restricted stock units (RSUs) on December 4, 2024.
• These RSUs vest over a 48-month period, with 1/16th of the total units vesting each quarter starting from November 20, 2024.
• The vesting is contingent upon Mr. Werner's continuous service with the company through each vesting date.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management with company performance. There are no indications of negative sentiment.

Positives

• The grant of RSUs aligns the executive's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and commitment from the Chief Accounting Officer.

Risks

• The value of the RSUs is subject to the market price of Twist Bioscience's stock, which can fluctuate.
• If Mr. Werner leaves the company before the vesting period is complete, he may forfeit unvested RSUs.

Future Outlook

The vesting of the RSUs is contingent on the continued service of the executive, suggesting a focus on long-term stability and performance.

Industry Context

Stock-based compensation, such as RSUs, is a common practice in the biotechnology industry to attract and retain key talent.

Comparison to Industry Standards

• RSU grants are a standard form of compensation for executives in the biotech industry, often used to align management interests with shareholder value.
• The vesting schedule of 48 months with quarterly vesting is a typical structure for such awards, similar to practices at companies like Illumina and Regeneron.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it incentivizes the executive to contribute to the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

restricted stock units, RSU, stock award, executive compensation, Twist Bioscience, Robert F. Werner, vesting